Medicus Pharma Ltd. cotiza a 3.28 USD y tiene una capitalización bursátil de $5M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Sy…
| Periodo | 2026-08 | 2026-05 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | $-10.50 | $-15.09 | $-22.21 | $-54.66 |
| Estimado | $-8.00 | $-11.00 | $-14.50 | $-19.00 |
| Sorpresa | -31.3% | -37.2% | -53.2% | -187.7% |
| Métrica | MDCX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -469.9% | -32.0% | -437.9% |
| Current Ratio | 1.00 | 2.84 | -1.84 |
| Debt / Equity | — | 0.28 | — |